So Near, Yet So Far: A Look at India’s Vaccine Push Caught Between Promise and Policy
Disclaimer: This post discusses a development from mid-March 2026. As readers of this blog are no doubt aware, vaccine policy in India has never quite been a straight road. It is always puddled with poor transparency and poorer access. Two developments (one involving an international IP licensing arrangement for a Nipah vaccine, and the other concerning the curious sidelining of an indigenous HPV vaccine, both involving the Serum Institute of India (SII)) offer another opportunity to assess the state of […]
So Near, Yet So Far: A Look at India’s Vaccine Push Caught Between Promise and Policy Read More »










